Literature DB >> 32741017

Chronic inducible urticaria subtypes in children: Clinical features and prognosis.

Fatma Bal1, Melike Kahveci2, Ozge Soyer2, Bulent Enis Sekerel2, Umit Murat Sahiner2.   

Abstract

BACKGROUND: Chronic inducible urticaria (CIndU) is a subtype of chronic urticaria induced by a physical stimulus.
OBJECTIVE: To evaluate the clinical features, prognostic factors, and natural course of childhood CIndU subtypes.
METHODS: Patients (1-18 years old, n = 117) diagnosed with CIndU between March 2011 and March 2019 were analyzed. Patients (n = 101) were re-evaluated for the status of their CIndU at least 6 months after the initial evaluation.
RESULTS: The study population comprised of 117 children with a median (inter-quartile range) age of 10.3 (6-14.8) years at admission and a male predominance (53%). Symptomatic dermographism was the most common type of CIndU, affecting 65% of the group, followed by cold urticaria and cholinergic urticaria, which affected 17% and 15.4%, respectively. Baseline serum tryptase levels in cholinergic urticaria and cold urticaria were higher than those in symptomatic dermographism [7.0 (3.3-10.7) μg/L, 4.2 (2.8-9.3) μg/L, and 2.7 μg/L (1.8-5.9), respectively; P = .020]. Recovery was observed in 9.6%, 25.3%, and 34.7% of the CIndU children after 12, 36, and 60 months, respectively. Of the patients with symptomatic dermographism, 40% had remission in 5 years, whereas this rate was only one-fifth in patients with cold urticaria. The worst prognosis was observed in patients with cholinergic urticaria.
CONCLUSION: This study concluded that nearly one-third of children with CIndU recovered within 5 years and symptomatic dermographism has the best prognosis. Cholinergic urticaria is the CIndU type with the worst prognosis, male dominance, and highest baseline serum tryptase levels.
© 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Entities:  

Keywords:  baseline serum tryptase; children; chronic inducible urticaria; chronic urticaria; prognosis

Year:  2020        PMID: 32741017     DOI: 10.1111/pai.13324

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  2 in total

1.  Urticaria in a Pediatric Population: A Portuguese Single-Center Cohort Report.

Authors:  Inês Coelho; Bárbara Neto; Diana Bordalo; Sylvia Jacob
Journal:  Cureus       Date:  2022-07-08

Review 2.  Urticaria.

Authors:  Pavel Kolkhir; Ana M Giménez-Arnau; Kanokvalai Kulthanan; Jonny Peter; Martin Metz; Marcus Maurer
Journal:  Nat Rev Dis Primers       Date:  2022-09-15       Impact factor: 65.038

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.